Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: a 6-year study in southern China
With the atypical rise of Mycoplasma pneumoniae infection (MPI) in 2023, prompt studies are needed to determine the current epidemic features and risk factors with emerging trends of MPI to furnish a framework for subsequent investigations. This multicentre, retrospective study was designed to analy...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor & Francis Group
2024-12-01
|
| Series: | Emerging Microbes and Infections |
| Subjects: | |
| Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2024.2353298 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850111837378445312 |
|---|---|
| author | Yi Xu Chen Yang Panpan Sun Fansen Zeng Qian Wang Jianlong Wu Chunxiao Fang Che Zhang Jinping Wang Yiling Gu Xiaohuan Wu Xiaoxian Zhang Bin Yang Juhua Yang Hongwei Zhang Jiacee Lian Jinqiu Zhang Li Huang Qizhou Lian |
| author_facet | Yi Xu Chen Yang Panpan Sun Fansen Zeng Qian Wang Jianlong Wu Chunxiao Fang Che Zhang Jinping Wang Yiling Gu Xiaohuan Wu Xiaoxian Zhang Bin Yang Juhua Yang Hongwei Zhang Jiacee Lian Jinqiu Zhang Li Huang Qizhou Lian |
| author_sort | Yi Xu |
| collection | DOAJ |
| description | With the atypical rise of Mycoplasma pneumoniae infection (MPI) in 2023, prompt studies are needed to determine the current epidemic features and risk factors with emerging trends of MPI to furnish a framework for subsequent investigations. This multicentre, retrospective study was designed to analyse the epidemic patterns of MPI before and after the COVID-19 pandemic, as well as genotypes and the macrolide-resistance-associated mutations in MP sampled from paediatric patients in Southern China. Clinical data was collected from 1,33,674 patients admitted into investigational hospitals from 1 June 2017 to 30 November 2023. Metagenomic next-generation sequencing (mNGS) data were retrieved based on MP sequence positive samples from 299 paediatric patients for macrolide-resistance-associated mutations analysis. Pearson's chi-squared test was used to compare categorical variables between different time frames. The monthly average cases of paediatric common respiratory infection diseases increased without enhanced public health measures after the pandemic, especially for influenza, respiratory syncytial virus infection, and MPI. The contribution of MPI to pneumoniae was similar to that in the outbreak in 2019. Compared to mNGS data between 2019–2022 and 2023, the severity of MP did not grow stronger despite higher rates of macrolide-resistance hypervariable sites, including loci 2063 and 2064, were detected in childhood MP samples of 2023. Our findings indicated that ongoing surveillance is necessary to understand the impact of post pandemic on MP transmission disruption during epidemic season and the severity of clinical outcomes in different scenarios. |
| format | Article |
| id | doaj-art-675a92502aaa442dadd2cc57c4bc87c2 |
| institution | OA Journals |
| issn | 2222-1751 |
| language | English |
| publishDate | 2024-12-01 |
| publisher | Taylor & Francis Group |
| record_format | Article |
| series | Emerging Microbes and Infections |
| spelling | doaj-art-675a92502aaa442dadd2cc57c4bc87c22025-08-20T02:37:32ZengTaylor & Francis GroupEmerging Microbes and Infections2222-17512024-12-0113110.1080/22221751.2024.2353298Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: a 6-year study in southern ChinaYi Xu0Chen Yang1Panpan Sun2Fansen Zeng3Qian Wang4Jianlong Wu5Chunxiao Fang6Che Zhang7Jinping Wang8Yiling Gu9Xiaohuan Wu10Xiaoxian Zhang11Bin Yang12Juhua Yang13Hongwei Zhang14Jiacee Lian15Jinqiu Zhang16Li Huang17Qizhou Lian18Department of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaPrenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaFaculty of Synthetic Biology, Shenzhen University of Advanced Technology; Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, People’s Republic of ChinaDepartment of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaDepartment of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaDepartment of Pharmacy, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, People’s Republic of ChinaDepartment of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaDepartment of Pharmacy, South China Hospital, Medical School, Shenzhen University, Shenzhen, People’s Republic of ChinaDepartment of Pharmacy, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen, People’s Republic of ChinaDepartment of Infectious Diseases, Guangzhou Children’s Hospital, Guangzhou, People’s Republic of ChinaDepartment of Infectious Diseases, Guangzhou Children’s Hospital, Guangzhou, People’s Republic of ChinaPrenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaVision Medicals Co., Ltd., Guangzhou, People’s Republic of ChinaVision Medicals Co., Ltd., Guangzhou, People’s Republic of ChinaDepartment of Navy Epidemiology, Faculty of Naval Medicine, Naval Medical University (Second Military Medical University), Shanghai, People’s Republic of ChinaSchool of Health Sciences, Ngee Ann Polytechnic, Singapore, SingaporePrenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaPrenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaPrenatal Diagnostic Center and Cord Blood Bank, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University, Guangzhou, People’s Republic of ChinaWith the atypical rise of Mycoplasma pneumoniae infection (MPI) in 2023, prompt studies are needed to determine the current epidemic features and risk factors with emerging trends of MPI to furnish a framework for subsequent investigations. This multicentre, retrospective study was designed to analyse the epidemic patterns of MPI before and after the COVID-19 pandemic, as well as genotypes and the macrolide-resistance-associated mutations in MP sampled from paediatric patients in Southern China. Clinical data was collected from 1,33,674 patients admitted into investigational hospitals from 1 June 2017 to 30 November 2023. Metagenomic next-generation sequencing (mNGS) data were retrieved based on MP sequence positive samples from 299 paediatric patients for macrolide-resistance-associated mutations analysis. Pearson's chi-squared test was used to compare categorical variables between different time frames. The monthly average cases of paediatric common respiratory infection diseases increased without enhanced public health measures after the pandemic, especially for influenza, respiratory syncytial virus infection, and MPI. The contribution of MPI to pneumoniae was similar to that in the outbreak in 2019. Compared to mNGS data between 2019–2022 and 2023, the severity of MP did not grow stronger despite higher rates of macrolide-resistance hypervariable sites, including loci 2063 and 2064, were detected in childhood MP samples of 2023. Our findings indicated that ongoing surveillance is necessary to understand the impact of post pandemic on MP transmission disruption during epidemic season and the severity of clinical outcomes in different scenarios.https://www.tandfonline.com/doi/10.1080/22221751.2024.2353298Mycoplasma pneumoniaemacrolide-resistance-associated mutationpublic health measurepaediatric infectious diseasespost COVID-19 pandemic |
| spellingShingle | Yi Xu Chen Yang Panpan Sun Fansen Zeng Qian Wang Jianlong Wu Chunxiao Fang Che Zhang Jinping Wang Yiling Gu Xiaohuan Wu Xiaoxian Zhang Bin Yang Juhua Yang Hongwei Zhang Jiacee Lian Jinqiu Zhang Li Huang Qizhou Lian Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: a 6-year study in southern China Emerging Microbes and Infections Mycoplasma pneumoniae macrolide-resistance-associated mutation public health measure paediatric infectious diseases post COVID-19 pandemic |
| title | Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: a 6-year study in southern China |
| title_full | Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: a 6-year study in southern China |
| title_fullStr | Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: a 6-year study in southern China |
| title_full_unstemmed | Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: a 6-year study in southern China |
| title_short | Epidemic features and megagenomic analysis of childhood Mycoplasma pneumoniae post COVID-19 pandemic: a 6-year study in southern China |
| title_sort | epidemic features and megagenomic analysis of childhood mycoplasma pneumoniae post covid 19 pandemic a 6 year study in southern china |
| topic | Mycoplasma pneumoniae macrolide-resistance-associated mutation public health measure paediatric infectious diseases post COVID-19 pandemic |
| url | https://www.tandfonline.com/doi/10.1080/22221751.2024.2353298 |
| work_keys_str_mv | AT yixu epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT chenyang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT panpansun epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT fansenzeng epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT qianwang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT jianlongwu epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT chunxiaofang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT chezhang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT jinpingwang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT yilinggu epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT xiaohuanwu epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT xiaoxianzhang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT binyang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT juhuayang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT hongweizhang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT jiaceelian epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT jinqiuzhang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT lihuang epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina AT qizhoulian epidemicfeaturesandmegagenomicanalysisofchildhoodmycoplasmapneumoniaepostcovid19pandemica6yearstudyinsouthernchina |